Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Livingston

Cancer

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer|August 1, 1994
Dose intensity and high dose therapy. Two different conceptsR B Livingston
Cancer|January 15, 1993
Feasibility of dose-intensive continuous 5-fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancerG Ellis, R B Livingston
Cancer|December 15, 1980
Evaluation and radiotherapy implications of chest relapse patterns in small cell lung carcinoma treated with radiotherapy-chemotherapy: study of 34 cases and review of the literatureJ G Mira, R B Livingston
Cancer|January 15, 1989
High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignanciesC Collins, J Mortimer, R B Livingston
Cancer|May 1, 1991
Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinomaM W Brunvand, C Collins, R B Livingston, et al.
Cancer|November 15, 1985
Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trialJ Mortimer, N Flournoy, R B Livingston, et al.
Cancer|June 15, 1989
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patientsG Ellis, M Ferguson, E Yamanaka, et al.
Cancer|June 15, 1991
Cisplatin and novobiocin in the treatment of non-small cell lung cancer. A Southwest Oncology Group studyG K Ellis, J Crowley, R B Livingston, et al.
Cancer|May 15, 1991
A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group studyC S Higano, J Crowley, R B Livingston, et al.
Cancer|December 15, 1989
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group StudyG K Ellis, S Green, S Schulman, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer|August 1, 1994
Dose intensity and high dose therapy. Two different conceptsR B Livingston
Cancer|January 15, 1993
Feasibility of dose-intensive continuous 5-fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancerG Ellis, R B Livingston
Cancer|December 15, 1980
Evaluation and radiotherapy implications of chest relapse patterns in small cell lung carcinoma treated with radiotherapy-chemotherapy: study of 34 cases and review of the literatureJ G Mira, R B Livingston
Cancer|January 15, 1989
High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignanciesC Collins, J Mortimer, R B Livingston
Cancer|May 1, 1991
Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinomaM W Brunvand, C Collins, R B Livingston, et al.
Cancer|November 15, 1985
Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trialJ Mortimer, N Flournoy, R B Livingston, et al.
Cancer|June 15, 1989
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patientsG Ellis, M Ferguson, E Yamanaka, et al.
Cancer|June 15, 1991
Cisplatin and novobiocin in the treatment of non-small cell lung cancer. A Southwest Oncology Group studyG K Ellis, J Crowley, R B Livingston, et al.
Cancer|May 15, 1991
A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group studyC S Higano, J Crowley, R B Livingston, et al.
Cancer|December 15, 1989
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group StudyG K Ellis, S Green, S Schulman, et al.
Pageof 3